SCHEMBL6829129

SCHEMBL6829129

CN(N=O)/C(N)=N\[N+](=O)[O-]

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL51611 1.00 ALDH1A1 (0.42) ALDH1A1TP53
SCHEMBL566952 1.00 ALDH1A1 (0.42) ALDH1A1TP53
SCHEMBL8801608 0.79
SCHEMBL10354564 0.79
SCHEMBL1168086 0.78 ALDH1A1 (0.32) ALDH1A1TP53
SCHEMBL2143726 0.78 ALDH1A1 (0.32) ALDH1A1TP53
SCHEMBL11735834 0.76
SCHEMBL5847104 0.76
SCHEMBL459531 0.76
SCHEMBL11478654 0.75 ALDH1A1 (0.30) ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115433191-B Dinitropyrazolo 1,2,3, 5-tetrazine-2-oxide and preparation method and application thereof 北京理工大学 2024-04-26 CN claimed
CN-115433191-A Dinitropyrazolo 1,2,3, 5-tetrazine-2-oxide, preparation method and application thereof 北京理工大学 2022-12-06 CN claimed
US-20260049318-A1 INHIBITION OF PLANT PROTEASE AED3-1 FOR IMPROVED HETEROLOGOUS PROTEIN PRODUCTION UNIV GUELPH (CA) 2026-02-19 US disclosed
CN-115433191-B Dinitropyrazolo 1,2,3, 5-tetrazine-2-oxide and preparation method and application thereof 北京理工大学 2024-04-26 CN disclosed
CN-115433191-A Dinitropyrazolo 1,2,3, 5-tetrazine-2-oxide, preparation method and application thereof 北京理工大学 2022-12-06 CN disclosed
US-10087496-B2 Green alga lipid-accumulating variant and use of the same DENSO CORPORATION (JP) 2018-10-02 US disclosed
US-20170226488-A1 FEEDBACK-RESISTANT ACETOHYDROXY ACID SYNTHASE VARIANT AND METHOD FOR PRODUCING L-VALINE USING THE SAME CJ CHEILJEDANG CORPORATION (KR) 2017-08-10 US disclosed
US-20160273061-A1 GREEN ALGA LIPID-ACCUMULATING VARIANT AND USE OF THE SAME DENSO CORPORATION (JP) 2016-09-22 US disclosed
US-9097722-B2 PARP substrates and biomarkers BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2015-08-04 US disclosed
US-20140371101-A1 PARP Substrates and Biomarkers BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-12-18 US disclosed
US-8828672-B2 PARP substrates and biomarkers BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-09-09 US disclosed
US-20140170643-A1 PARP Substrates and Biomarkers BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-06-19 US disclosed
US-20120159673-A1 GENE FOR INCREASING PLANT WEIGHT AND METHOD FOR USING THE SAME TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2012-06-21 US disclosed
US-20040152154-A1 Method of producing $g(b)-carotene by means of mixed culture fermentation using (+) and (—) strains of blakeslea trispora DSM IP ASSETS B.V. (NL) 2004-08-05 US disclosed
US-20020160461-A1 Method for producing substance utilizing microorganism AJINOMOTO CO., INC. (JP) 2002-10-31 US disclosed
US-6294380-B1 Liver cell clones for use in extracorporeal liver-assist device JMS CO., LTD. (JP) 2001-09-25 US disclosed
EP-1063289-A1 Liver cell clones for artifical liver and extracorporeal liver assist device JMS Co., Ltd. (JP) 2000-12-27 EP disclosed
US-5829448-A ANTITUMOR PHOTOGEN, INC. (US) 1998-11-03 US disclosed
WO-1984001388-A1 METHOD FOR DETECTING THE MUTAGENICITY OF SUBSTANCES SUSCEPTIBLE OF INDUCING THE DETERIORATION OF CELLULAR DNA, UTILIZING THE PRODUCTION OF AN SOS RESPONSE PASTEUR INSTITUT (FR) 1984-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049318-A1 INHIBITION OF PLANT PROTEASE AED3-1 FOR IMPROVED HETEROLOGOUS PROTEIN PRODUCTION DPP3, IDE, NOTCH3 ALDH1A1 4141/4885TP53 1352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.